EGFR and lung adenocarcinoma: The short in-frame deletions of exon 19 (Exon19 in-frame deletion) mutation and the single-point substitution of leucine by arginine at codon 858 (L858R) mutation are located in the tyrosine kinase domain and account for approximately 90% of all EGFR mutations in lung adenocarcinoma [4,5].